Clinical Trial Update: Effect of Ivabradine on Patients With Postural Orthostatic Tachycardia Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the effect of ivabradine in patients with Postural Orthostatic Tachycardia Syndrome has completed with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postural Orthostatic Tachycardia Syndrome

Drugs mentioned

• IVABRADINE

Snippet

Sponsor: University of California, San Diego | Conditions: Postural Orthostatic Tachycardia Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2021-06-29